comparemela.com

Latest Breaking News On - பிரிவு ஆஃப் புற்றுநோய் தொற்றுநோய் - Page 6 : comparemela.com

Investegate |International Association for Announcements | International Association for: Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities

International Association for Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities Press Briefing at IASLC World Conference on Lung Cancer 2020 Singapore SINGAPORE, Jan. 28, 2021 (GLOBE NEWSWIRE) Several leading international lung cancer researchers at a press today presented compelling new data revealing that factors of race, gender, sexual orientation and income continue to be significant barriers to those living with lung cancer. The press briefing is part of the IASLC’s World Conference on Lung Cancer 2020 Singapore. 

NCI s Hildesheim Retires | NIH Record

Dr. Allan Hildesheim Dr. Allan Hildesheim, senior investigator and former chief of the Infections and Immunoepidemiology Branch (IIB), retired from NCI’s Division of Cancer Epidemiology and Genetics after 33 years of service at the end of 2020.  As the inaugural chief of IIB, Hildesheim built a multidisciplinary research program focused on the interplay of infection, immunity and inflammation on cancer risk and helped translate those findings into important advances in cancer prevention, risk stratification and screening. As an investigator, he devoted his career to the study of host and viral factors involved in the pathogenesis of DNA virus-related tumors. Hildesheim began his career at NCI in 1987 as a predoctoral fellow in the precursor to DCEG, the Division of Cancer Etiology. He earned his Ph.D. in epidemiology from Johns Hopkins School of Hygiene and Public Health in 1991 and completed his doctoral dissertation studying the interactions of herpes simplex virus 2 (HSV2) a

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.